Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Goodwill & Intangibles: 2012-2025

Historic Goodwill & Intangibles for Ani Pharmaceuticals (ANIP) over the last 13 years, with Sep 2025 value amounting to $562.3 million.

  • Ani Pharmaceuticals' Goodwill & Intangibles fell 10.78% to $562.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $562.3 million, marking a year-over-year decrease of 10.78%. This contributed to the annual value of $601.8 million for FY2024, which is 153.69% up from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Goodwill & Intangibles of $562.3 million as of Q3 2025, which was down 3.19% from $580.9 million recorded in Q2 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Goodwill & Intangibles peaked at $630.3 million during Q3 2024, and registered a low of $173.7 million during Q3 2021.
  • In the last 3 years, Ani Pharmaceuticals' Goodwill & Intangibles had a median value of $535.7 million in 2023 and averaged $426.3 million.
  • In the last 5 years, Ani Pharmaceuticals' Goodwill & Intangibles soared by 208.37% in 2022 and then crashed by 58.14% in 2024.
  • Ani Pharmaceuticals' Goodwill & Intangibles (Quarterly) stood at $528.4 million in 2021, then slumped by 47.04% to $279.9 million in 2022, then declined by 15.23% to $237.2 million in 2023, then surged by 153.69% to $601.8 million in 2024, then decreased by 10.78% to $562.3 million in 2025.
  • Its Goodwill & Intangibles was $562.3 million in Q3 2025, compared to $580.9 million in Q2 2025 and $599.2 million in Q1 2025.